Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$14.08
+7.61%
Mkt Cap $10.94B
Analyst Ratings
Buy
4
Hold
4
Sell
0
Price Target (18 analysts)
$26.00
Range $16.00 – $40.00
Implied Upside
+84.7%
Consensus $26.00 vs current $14.08
NASDAQ·Healthcare·Biotechnology
$14.08
+7.61%
Mkt Cap $10.94B
Buy
4
Hold
4
Sell
0
Price Target (18 analysts)
$26.00
Range $16.00 – $40.00
+84.7%
Consensus $26.00 vs current $14.08